ritterazine B

ritterazine analog extracted from Ritterella tokioka, has been shown to be chemically similar to cephalostatin 1; structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Anderson, D Ryan: 1 article (08/2011)
2.	Burgett, Anthony W G: 1 article (08/2011)
3.	Cornella-Taracido, Ivan: 1 article (08/2011)
4.	Fortner, Kevin C: 1 article (08/2011)
5.	Kikuchi, Chikako: 1 article (08/2011)
6.	Kuroda, Minpei: 1 article (08/2011)
7.	Mimaki, Yoshihiro: 1 article (08/2011)
8.	Murphy, Jason P: 1 article (08/2011)
9.	Okubo, Shuichi: 1 article (08/2011)
10.	Petrella, Eugene C: 1 article (08/2011)

1.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/01/2003 - "The objective of this study was to determine the cytotoxicity of ritterazine B to non-small-cell lung cancer (NSCLC) cells in vitro and its effects on the cell cycle and apoptosis. "
2.	Neoplasms (Cancer) 03/01/2003 - "Ritterazine B, a new cytotoxic natural compound, induces apoptosis in cancer cells." 08/07/2011 - "Cephalostatin 1, OSW-1, ritterazine B and schweinfurthin A are natural products that potently, and in some cases selectively, inhibit the growth of cultured human cancer cell lines. "
3.	Leukemia 03/01/2003 - "Ritterazine B, one of the ritterazine analogues extracted from Ritterella tokioka, has been shown to be chemically similar to cephalostatin 1, and among the ritterazine derivatives is the most cytotoxic to P388 murine leukemia cells. "